Transplantation Market: By Organ Type, By Product Type, By End User, Specialized Transplant Centers) and Region Forecast 2020-2031

Transplantation Market Size, Share, Growth, Trends, and Global Industry Analysis: By Organ Type (Kidney Transplants, Liver Transplants, Heart Transplants, Lung Transplants, Pancreas Transplants, Intestine Transplants), By Product Type (Immunosuppressive Drugs, Organ Preservation Solutions, Diagnostic Tools, Surgical Instruments), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Transplant Centers) and Region Forecast 2020-2031

Transplantation Market size was valued at US$ 14,892.7 million in 2024 and is expected to reach US$ 26,362.2 million by 2031, growing at a significant CAGR of 8.5% from 2025-2031. The market refers to the global industry involved in the surgical removal and implantation of human organs, tissues, or cells to replace damaged or failing biological structures. This market encompasses various products and services, including immunosuppressive drugs, organ preservation solutions, and transplant diagnostics.

The market has experienced steady growth due to the rising incidence of organ failure, chronic diseases, and advancements in transplant techniques. An increasing number of transplant procedures, government initiatives supporting organ donation, and technological innovations in tissue engineering and preservation are major drivers of the market. However, the shortage of donor organs and high treatment costs remain significant challenges.

Transplantation Market

Facts & Figures

  • Over 130,000 organ transplants are performed worldwide each year, with kidney transplants making up nearly 60% of these procedures.
  • The global shortage of donor organs leads to an average waiting time of 3 to 5 years for patients on transplant lists in many countries.
  • Advances in immunosuppressive drugs have increased the 5-year survival rate of organ transplant recipients to over 85% in developed regions.

Key Developments:

  • In December 2024, surgeons at Royal Papworth Hospital in Cambridge conducted the UK's first double-lung transplant utilizing the XPS system by Xvivo. This innovative machine revives and maintains donor lungs outside the body, extending their viability beyond traditional ice storage methods. The procedure marks a significant advancement in organ preservation and could potentially increase the number of lungs available for transplantation in the NHS.
  • In February 2025, Cleveland Clinic announced that it transplanted 1,357 donated organs in 2024, marking a 9.8% increase from the previous year. This achievement underscores the clinic's commitment to expanding transplant access and improving patient outcomes through technological innovations like machine perfusion and robotic-assisted surgeries.

Transplantation Market Segmentation:

Based on the Organ type:

  • Kidney Transplants
  • Liver Transplants
  • Heart Transplants
  • Lung Transplants
  • Pancreas Transplants
  • Intestine Transplants

Among the various organ types, kidney transplants are anticipated to lead the market. The primary driver behind this growth is the rising prevalence of chronic kidney disease (CKD) and end-stage renal failure, which affects millions globally. In particular, diabetes and hypertension are major contributors to kidney failure, creating an increased demand for kidney transplants. The ongoing improvements in transplant techniques, along with advances in immunosuppressive therapy, have significantly enhanced patient outcomes and extended transplant longevity. This growing demand for kidney transplants, coupled with the increasing focus on organ donation, positions kidney transplantation as the leading segment in the market.

Based on the product type:

  • Immunosuppressive Drugs
  • Organ Preservation Solutions
  • Diagnostic Tools
  • Surgical Instruments

Among the various product types, immunosuppressive drugs are expected to lead the market. The demand for these drugs is primarily driven by the need to prevent organ rejection after transplantation. As the number of transplant procedures increases, so does the reliance on effective immunosuppressive therapies to ensure the longevity of transplanted organs. Advances in drug formulations, aimed at improving efficacy while reducing side effects, have contributed significantly to the growth of this segment. Immunosuppressive drugs are critical for enhancing transplant success rates, making them a central focus in the market, particularly in developed healthcare systems.

Based on the end user:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialized Transplant Centers

Among the various end-users, hospitals are anticipated to lead the market. The primary driver for this growth is the comprehensive healthcare infrastructure offered by hospitals, which are equipped with specialized transplant units, experienced medical staff, and advanced technologies required for complex transplant procedures. Hospitals provide the full range of services, from organ procurement and surgery to post-transplant care, making them the most preferred setting for transplantations. Additionally, hospitals are increasingly adopting innovative technologies and surgical techniques, which further boosts their role in the market, positioning them as the dominant end-user segment.

Transplantation Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

8.5%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Transplantation Market Dynamics

Drivers

One of the key drivers fueling the market is the rising incidence of chronic diseases that cause organ failure. Diabetes, hypertension, chronic kidney disease (CKD), and cardiovascular diseases have become more prevalent as a result of aging populations, lack of exercise, and unhealthy diets across the world. Consequently, the number of patients in need of life-saving organ transplants kidney, liver, and heart transplants has risen sharply. Non-communicable diseases, according to the World Health Organization (WHO), contribute to more than 70% of all global mortality, much of which is due to organ dysfunction or failure.

The expanding burden of end-stage organ diseases has generated steady demand for transplant procedures. Developed and developing world healthcare systems are reacting with increased investment in transplant facilities, publicity campaigns regarding organ donation, and enhanced screening for early intervention. These combined factors make the increasing prevalence of chronic diseases a key long-term driver of the market.

Restraints

One major restraint on the development of the market is the ongoing shortage of donor organs in comparison with demand. Despite multiple campaigns raising awareness and enhanced organ donation legislation, the supply of organs from both living and deceased donors falls well short of global transplantation demand. This shortfall creates lengthy waiting lists and, in most instances, death before a compatible organ is found. The process is also complicated by regulatory, cultural, and logistical issues that complicate the organ donation process in most nations. For example, religious convictions or lack of trust in healthcare systems can lower the level of willingness among people to donate organs.

Moreover, the intricate coordination involved in organ procurement, preservation, and transportation within critical time frames makes the process extremely sensitive and susceptible to interference. This lack of donor organs is one of the big obstacles that stifle the potential expansion and achievement of the market, particularly among countries with underdeveloped health care systems.

Opportunities

A new development in the transplant market is found in the expanding arena of regenerative medicine and stem cell technology. These technologies hold promise to transform transplant treatment by minimizing reliance on donor organs and facilitating the regeneration of injured tissues or organs. Stem cell research in pluripotent stem cells and tissue engineering has been promising to develop bioartificial organs, which may one day be used to replace faulty kidneys, livers, and even hearts.

Additionally, stem cells are being researched more and more for their potential to induce immune tolerance and lower the chances of graft rejection, a frequent side effect in transplants. Bioprinting, where 3D printing technology is used to build tissues layer by layer, is also being explored as a potential solution to the organ shortage problem in the future. With clinical trials underway and regulatory structures changing to meet these new developments, regenerative medicine presents a revolutionary chance to increase the range, safety, and accessibility of transplantation treatments across the world.

Trends

A key trend in the transplant market is the increasing use of minimally invasive and robotic-assisted surgical methods. Classical transplant procedures typically involve large incisions, longer hospital stays, and increased risks of postoperative complications. Yet with recent technological improvements, surgeons are now able to conduct complex transplant procedures with laparoscopic and robotic-assisted methods that are more accurate and less traumatic to the patient. Robotic platforms such as the da Vinci Surgical System are increasingly being utilized for kidney and liver transplants in specialized centres, providing advantages such as less blood loss, shorter hospitalization, and quicker recovery.

This transition not only improves patient outcomes but also decreases the load on healthcare systems by limiting complications and hospital stay. As more transplant centers and hospitals invest in robotic platforms and train specialized staff, this trend is likely to redefine the quality of care in transplant procedures and establish new standards for procedural safety and efficiency.

Transplantation Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 14,892.7 million

Market Size in 2031

US$ 26,362.2 million

Market CAGR

8.5%

By Organ Type

  • Kidney Transplants
  • Liver Transplants
  • Heart Transplants
  • Lung Transplants
  • Pancreas Transplants
  • Intestine Transplants 

By Product Type

  • Immunosuppressive Drugs
  • Organ Preservation Solutions
  • Diagnostic Tools
  • Surgical Instruments

By End User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialized Transplant Centers 

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Analyst Review

PBI Analysts anticipate that the market is on a steady growth trajectory, driven by rising incidences of organ failure, advancements in surgical techniques, and increasing awareness of organ donation. Kidney transplants remain the most in-demand, while immunosuppressive drugs dominate the product segment due to their essential role in transplant success. Hospitals lead as primary end-users, supported by advanced infrastructure and specialist care.

However, challenges such as donor shortages and high treatment costs persist. PBI Analysts anticipate continued innovation in regenerative medicine and robotic-assisted surgery, which are expected to reshape the future of transplantation and expand market potential globally.

Key Features of the Report

  • The transplantation market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter Five Force Analysis.

Download Free Sample Report

Frequently Asked Questions

The transplantation market size was valued at US$ 14,892.7 million in 2024 and is projected to grow at a significant CAGR of 8.5% from 2025-2031.

The increasing prevalence of chronic diseases such as kidney failure is significantly driving the demand for organ transplantation.

The growing adoption of minimally invasive and robotic-assisted transplant surgeries is transforming procedural efficiency and patient outcomes.

In Asia Pacific, rising healthcare investments and government initiatives promoting organ donation are fueling rapid market growth.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Transplantation Market Introduction 
2.1.Global Transplantation Market  - Taxonomy
2.2.Global Transplantation Market  - Definitions
2.2.1.Organ Type
2.2.2.Product Type
2.2.3. End User
2.2.4.Region
3.Global Transplantation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Transplantation Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Transplantation Market  By Organ Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Kidney Transplants
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Liver Transplants
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Heart Transplants
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Lung Transplants
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Pancreas Transplants
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Intestine Transplants 
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Transplantation Market  By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Immunosuppressive Drugs
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Organ Preservation Solutions
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Diagnostic Tools
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Surgical Instruments
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Transplantation Market  By  End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ambulatory Surgical Centers (ASCs)
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Specialized Transplant Centers 
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Transplantation Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Transplantation Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Organ Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Kidney Transplants
9.1.2.Liver Transplants
9.1.3.Heart Transplants
9.1.4.Lung Transplants
9.1.5.Pancreas Transplants
9.1.6.Intestine Transplants 
9.2.  Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Immunosuppressive Drugs
9.2.2.Organ Preservation Solutions
9.2.3.Diagnostic Tools
9.2.4.Surgical Instruments
9.3.   End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Ambulatory Surgical Centers (ASCs)
9.3.3.Specialized Transplant Centers 
9.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Transplantation Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Organ Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Kidney Transplants
10.1.2.Liver Transplants
10.1.3.Heart Transplants
10.1.4.Lung Transplants
10.1.5.Pancreas Transplants
10.1.6.Intestine Transplants 
10.2.  Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Immunosuppressive Drugs
10.2.2.Organ Preservation Solutions
10.2.3.Diagnostic Tools
10.2.4.Surgical Instruments
10.3.   End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Ambulatory Surgical Centers (ASCs)
10.3.3.Specialized Transplant Centers 
10.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Transplantation Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Organ Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Kidney Transplants
11.1.2.Liver Transplants
11.1.3.Heart Transplants
11.1.4.Lung Transplants
11.1.5.Pancreas Transplants
11.1.6.Intestine Transplants 
11.2.  Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Immunosuppressive Drugs
11.2.2.Organ Preservation Solutions
11.2.3.Diagnostic Tools
11.2.4.Surgical Instruments
11.3.   End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Ambulatory Surgical Centers (ASCs)
11.3.3.Specialized Transplant Centers 
11.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Transplantation Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Organ Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Kidney Transplants
12.1.2.Liver Transplants
12.1.3.Heart Transplants
12.1.4.Lung Transplants
12.1.5.Pancreas Transplants
12.1.6.Intestine Transplants 
12.2.  Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Immunosuppressive Drugs
12.2.2.Organ Preservation Solutions
12.2.3.Diagnostic Tools
12.2.4.Surgical Instruments
12.3.   End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Ambulatory Surgical Centers (ASCs)
12.3.3.Specialized Transplant Centers 
12.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Transplantation Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Organ Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Kidney Transplants
13.1.2.Liver Transplants
13.1.3.Heart Transplants
13.1.4.Lung Transplants
13.1.5.Pancreas Transplants
13.1.6.Intestine Transplants 
13.2.  Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Immunosuppressive Drugs
13.2.2.Organ Preservation Solutions
13.2.3.Diagnostic Tools
13.2.4.Surgical Instruments
13.3.   End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Ambulatory Surgical Centers (ASCs)
13.3.3.Specialized Transplant Centers 
13.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Novartis AG
14.2.2.Hoffmann-La Roche Ltd.
14.2.3.Pfizer Inc.
14.2.4.Astellas Pharma Inc.
14.2.5.Bristol-Myers Squibb Company
14.2.6.Sanofi S.A.
14.2.7.Johnson & Johnson
14.2.8.Baxter International Inc.
14.2.9.Thermo Fisher Scientific Inc.
14.2.10.Organ Recovery Systems, Inc.
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Novartis AG
  • Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Astellas Pharma Inc.
  • Bristol-Myers Squibb Company
  • Sanofi S.A.
  • Johnson & Johnson
  • Baxter International Inc.
  • Thermo Fisher Scientific Inc.
  • Organ Recovery Systems, Inc.

Related Industry Reports